Phase II Trial of Combination of Pegylated Liposomal Doxorubicin, Cisplatin, and Infusional 5-Fluorouracil (CCF) Plus Trastuzumab as Preoperative Treatment for Locally Advanced and Inflammatory Breast Cancer
- 31 December 2010
- journal article
- Published by Elsevier BV in Clinical Breast Cancer
- Vol. 10 (6), 483-488
- https://doi.org/10.3816/cbc.2010.n.064
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohortThe Lancet, 2010
- Metastatic breast cancer: The role of pegylated liposomal doxorubicin after conventional anthracyclinesCancer Treatment Reviews, 2008
- HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized TrialsJNCI Journal of the National Cancer Institute, 2008
- A randomized phase II trial comparing preoperative plus perioperative chemotherapy with preoperative chemotherapy in patients with locally advanced breast cancerAnti-Cancer Drugs, 2006
- A novel continuous infusional 5-fluorouracil-based chemotherapy regimen compared with conventional chemotherapy in theneo-adjuvant treatment of early breast cancer: 5 year results of the TOPIC trialAnnals of Oncology, 2004
- Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancerAnnals of Oncology, 2004
- Congestive heart failure in patients treated with doxorubicinCancer, 2003
- Liposomal anthracyclines for breast cancer.Seminars in Oncology, 2001
- Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2The New England Journal of Medicine, 2001
- Polyethylenglykol-umhülltes (pegyliertes) liposomales DoxorubicinDrugs, 1997